Naturally occurring products in cancer therapy

Journal of Pharmacy and Bioallied Sciences

Volumn 7, Issue , 2015, Pages S181-S183

  Rajesh, E ^a   Sankari, Leena ^a   Malathi, L ^a   Krupaa, Jayasri R ^a  

^a SREE BALAJI DENTAL COLLEGE AND HOSPITAL   (India)

Author keywords

Carcinogenesis; curcumin; quercetin

Indexed keywords

APIGENIN; CURCUMIN; GENISTEIN; ISOCYANIC ACID DERIVATIVE; PLANT MEDICINAL PRODUCT; QUERCETIN; RESVERATROL; URSOLIC ACID;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER CONTROL; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CHEMOPROPHYLAXIS; DIET THERAPY; FOOD INTAKE; HUMAN; MOUTH CANCER; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; REVIEW;

EID: 84928945719     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.155895     Document Type: Review

References (33)

1. Cancer Report worldwide. Press Release WCD 2014, Crisis of Cancer Impact Worldwide; 2014.
2. Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008;25:2097-116.
3. Donaldron MS. Nutrition and cancer. A review of the evidence for an anticancer diet. Nutrition journal 2004;3:1-21
4. Riboli E, Norat T. Epidemiological evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003;78 (3 suppl):559-69s.
5. Nichenametla SN, Taruscio TG, Barney DL, Exon JH. A review of the effects and mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr 2006;46:161-83.
6. Hollman PC, Katan MB. Dietary flavonoids: Intake, health effects and bioavailability. Food Chem Toxicol 1999;37:937-42.
7. Di Carlo G, Mascolo N, Izzo AA, Capasso F. Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sci 1999;65:337-53.
8. Cragg GM, Newman DJ. Natural products branch. Developmental therapeutics program, Division of cancer, treatment and diagnosis. Maryland: National Cancer Institute; 2007. p. 461-77.
9. Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. J Clin Oncol 2009;27:2712-25.
10. Menon VP, Sudheer AR. Antioxidant and anti?inflammatory properties of curcumin. In: Aggarwal BB, Surh YJ, Shishodia S, editors. The Molecular Targets and Therapeutic Uses of Urcumin in Health and Disease. US, Texas: Springer; 2007. p. 105-25.
11. Surh YJ, Chun KS. Cancer chemopreventive effects of curcumin. In: Aggarwal BB, Surh YJ, Shishodia S, editors. The Molecular Targets and Therapeutic Uses of Urcumin in Health and Disease. London: Springer; 2007. p. 149-72.
12. Kim JH, Xu C, Keum YS, Reddy B, Conney A, Kong AN. Inhibition of EGFR signaling in human prostate cancer PC?3 cells by combination treatment with beta?phenylethyl isothiocyanate and curcumin. Carcinogenesis 2006;27:475-82.
13. Gagliano N, Aldini G, Colombo G, Rossi R, Colombo R, Gioia M, et al. The potential of resveratrol against human gliomas. Anticancer Drugs 2010;21:140-50.
14. Huang X, Zhu HL. Resveratrol and its analogues: Promising antitumor agents. Anticancer Agents Med Chem 2011;11:479-90.
15. Yu HB, Pan CE, Wu WJ, Zhao SH, Zhang HF. Effects of resveratrol on matrix metalloproteinase?9 expression in hepatoma cells. Zhong Xi Yi Jie He Xue Bao 2008;6:270-3.
16. Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL. Multiple molecular targets of resveratrol: Anti?carcinogenic mechanisms. Arch Biochem Biophys 2009;486:95-102.
17. Patel D, Shukla S, Gupta S. Apigenin and cancer chemoprevention: Progress, potential and promise (review). Int J Oncol 2007;30:233-45.
18. Wei H, Tye L, Bresnick E, Birt DF. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 1990;50:499-502.
19. Birt DF, Mitchell D, Gold B, Pour P, Pinch HC. Inhibition of ultraviolet alight induced skin carcinogenesis in SKH?1 mice by apigenin, a plant flavonoid. Anticancer Res 1997;17:85-91.
20. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673-751.
21. Kelly GS. Quercetin. Monograph. Altern Med Rev 2011;16:172-94.
22. Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001;21:381-406.
23. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants: Determination of radical?scavenging efficiencies. Methods Enzymol 1990;186:343-55.
24. Prior RL. Fruits and vegetables in the prevention of cellular oxidative damage. Am J Clin Nutr 2003;78:570-8S.
25. Day AJ, Bao Y, Morgan MR, Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 2000;29:1234-43.
26. Lamson DW, Brignall MS. Antioxidants and cancer, part 3: Quercetin. Altern Med Rev 2000;5:196-208.
27. Cavell BE, Alwi SS, Donlevy A, Packham G. Antiangiogenic effects of dietary isothiocyanates; mechanisms of action and implications for human health. Biochem Pharmacol 2010;81:327-36.
28. Lam TK, Gallicchio L, Lindsley K, Shiels M, Hammond E, Tao XG, et al. Cruciferous vegetable consumption and lung cancer risk: A systematic review. Cancer Epidemiol Biomarkers Prev 2009;18:184-95.
29. Mi L, Di Pasqua AJ, Chung FL. Proteins as binding targets of isothiocyanates in cancer prevention. Carcinogenesis 2011;32:1405-13.
30. Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995;125:790-7S.
31. Li W, Frame LT, Hirsch S, Cobos E. Genistein and hematological malignancies. Cancer Lett 2010;296:1-8.
32. Barnes S. Effect of genistein on in vitro and in vitro models of cancer. J Nutr 1995;125 3 Suppl: 777-83S.
33. Mizushina Y, Iida A, Ohta K, Sugawara F, Sakaguchi K. Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochem J 2000;350:757-63.